Boston Scientific is acquiring SoniVie, the developer of the catheter-based Tivus intravascular ultrasound system. With a ...

Boston Scientific recently announced it entered into a definitive agreement to acquire SoniVie Ltd. According to the press release, SoniVie is ...

Boston Scientific has announced a definitive agreement to acquire SoniVie, the developer of the catheter-based Tivus intravascular ultrasound system. With a current equity stake of nearly 10% in ...

Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating ...

An investigational technology, the TIVUS system is designed to denervate nerves surrounding blood vessels to treat a variety of hypertensive disorders, including renal artery denervation (RDN ...

SoniVie is a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System. An investigational technology, the TIVUS system is designed to denervate nerves ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.